πŸ‡ΊπŸ‡Έ FDA
Patent

US 7223783

Indolinone derivatives

granted A61PA61P35/00A61P35/02

Quick answer

US patent 7223783 (Indolinone derivatives) held by Theravance, Inc. expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00, A61P35/02, A61P43/00, A61P9/08